Analysis of Personalistic Characteristics in Patients with Migraine and Medication-overuse Headache_West China Medical Journal

Authors：

 LiuYong ,  ZhangBiao , YiXingyang , WangChun , LiuPing

Department of Neurological Medicine, People's Hospital of Deyang City, Deyang, Sichuan 618000, P. R. China;

Corresponding author：

ZhangBiao, Email: zb_815@sina.com

Keywords：

Migraine; Medication-overuse headache; Minnesota multiphasic personality inventory

DOI：

10.7507/1002-0179.201600541

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To explore the personalistic characteristics of patients with migraine and medication-overuse headache (MOH), and to provide scientific evidence for mental treatment of these patients. Methods The subjects were divided into three groups:migraine group, MOH group, and health group.Patients with migraine or MOH, admitted to the Deyang People's Hospital from March 2012 to March 2014, were selected in this study.In addition, healthy volunteers were selected as controls at the same time.Data were collected through the Minnesota multiphasic personality inventory computer testing software, and differences of personalistic characteristics were compared among patients with migraine, MOH and controls. Results Patients with migraine and MOH had mental problems and the occurrence rate of psychological problems of MOH patients was significantly higher than that of migraine patients (χ²=6.055, P=0.014).Migraine patients showed higher scores of hypochondriasis, depression, hysteria, psychasthenia, hypomania than controls (P < 0.01).Compared with migraine patients, the scales of hypochondriasis, depression, hysteria, paranoia, schizophrenia were higher in MOH patients (P < 0.01). Conclusions Patients with migraine and MOH have personalistic and psychological problems.Early screening of personalistic characteristics and mental interventions may improve the clinical outcome of patients with migraine or MOH.

Citation： LiuYong, ZhangBiao, YiXingyang, WangChun, LiuPing. Analysis of Personalistic Characteristics in Patients with Migraine and Medication-overuse Headache. West China Medical Journal, 2016, 31(12): 1967-1970. doi: 10.7507/1002-0179.201600541 Copy

1.	Moriarty M, Mallick-Searle T. Diagnosis and treatment for chronic migraine[J]. Nurse Pract, 2016, 41(6):18-32.
2.	Davis RE, Smitherman TA, Baskin SM. Personality traits, personality disorders, and migraine:a review[J]. Neurol Sci, 2013, 34(1):7-10.
3.	Thorlund K, Sun-Edelstein C, Druyts E, et al. Risk of medication overuse headache across classes of treatments for acute migraine[J]. J Headache Pain, 2016, 17(1):107-116.
4.	彭雪梅, 李蔡敏. 86例偏头痛患者MMPI测试结果分析[J].重庆医学, 2014, 43(5):532-533.
5.	Headache Classification Committee. The international classification of headache disorders:2nd edition[J]. Cephalalgia, 2004, 24(1):9-160.
6.	Munoz I, Elena Toribio-Diaz M, Carod-Artal FJ, et al. Personality traits in patients with migraine:a multi-centre study using the Salamanca screening questionnaire[J]. Rev Neurol, 2013, 57(12):529-534.
7.	王翔, 陈宁, 郭江, 等.门诊原发性头痛患者就诊类型研究[J].华西医学, 2014, 29(6):1106-1108.
8.	鄢波, 周东.神经系统慢性疾病的综合管理[J].华西医学, 2015, 30(4):601-603.
9.	Cieslak M, Czarnecka J, Roszek KA. The role of purinergic signaling in the etiology of migraine and novel antimigraine treatment[J]. Purinergic Signal, 2015, 11(3):307-316.
10.	Dhillon KS, Singh J, Lyall JS. A new horizon into the pathobiology, etiology and treatment of migraine[J]. Med Hypotheses, 2011, 77(1):147-151.
11.	Wang YC, Huang YP, Wang MT, et al. Increased risk of rheumatoid arthritis in patients with migraine:a population-based, propensity score-matched cohort study[J]. Rheumatol Int, 2016, 11:1-7.
12.	Aurora SK, Brin MF. Chronic migraine:an update on physiology, imaging, and the mechanism of action of two available pharmacologic therapies[J/OL]. Headache, 2016:1-17. http://onlinelibrary.wiley.com/doi/10.1111/head.12999/abstract.
13.	吴江, 贾建平, 崔丽英, 等.神经病学[M]. 2版.北京:人民卫生出版社, 2010:314-315.
14.	Karakurum B, Soylu O, Karataş M, et al. Personality, depression, and anxiety as risk factors for chronic migraine[J]. Int J Neurosci, 2004, 114(11):1391-1399.
15.	Tan HJ, Suganthi C, Dhachayani S, et al. The coexistence of anxiety and depressive personality traits in migraine[J]. Singapore Med J, 2007, 48(4):307-310.
16.	Da Silva AN, Lake IA. Clinical aspects of medication overuse headaches[J]. Headache, 2014, 54(1):211-217.
17.	Cheung V, Amoozegar F, Dilli E. Medication overuse headache[J]. Curr Neurol Neurosci Rep, 2014, 15(1):509-517.
18.	Munksgaard SB, Jensen RH. Medication overuse headache[J]. Headache, 2014, 54(7):1251-1257.

1. Moriarty M, Mallick-Searle T. Diagnosis and treatment for chronic migraine[J]. Nurse Pract, 2016, 41(6):18-32.
2. Davis RE, Smitherman TA, Baskin SM. Personality traits, personality disorders, and migraine:a review[J]. Neurol Sci, 2013, 34(1):7-10.
3. Thorlund K, Sun-Edelstein C, Druyts E, et al. Risk of medication overuse headache across classes of treatments for acute migraine[J]. J Headache Pain, 2016, 17(1):107-116.
4. 彭雪梅, 李蔡敏. 86例偏头痛患者MMPI测试结果分析[J].重庆医学, 2014, 43(5):532-533.
5. Headache Classification Committee. The international classification of headache disorders:2nd edition[J]. Cephalalgia, 2004, 24(1):9-160.
6. Munoz I, Elena Toribio-Diaz M, Carod-Artal FJ, et al. Personality traits in patients with migraine:a multi-centre study using the Salamanca screening questionnaire[J]. Rev Neurol, 2013, 57(12):529-534.
7. 王翔, 陈宁, 郭江, 等.门诊原发性头痛患者就诊类型研究[J].华西医学, 2014, 29(6):1106-1108.
8. 鄢波, 周东.神经系统慢性疾病的综合管理[J].华西医学, 2015, 30(4):601-603.
9. Cieslak M, Czarnecka J, Roszek KA. The role of purinergic signaling in the etiology of migraine and novel antimigraine treatment[J]. Purinergic Signal, 2015, 11(3):307-316.
10. Dhillon KS, Singh J, Lyall JS. A new horizon into the pathobiology, etiology and treatment of migraine[J]. Med Hypotheses, 2011, 77(1):147-151.
11. Wang YC, Huang YP, Wang MT, et al. Increased risk of rheumatoid arthritis in patients with migraine:a population-based, propensity score-matched cohort study[J]. Rheumatol Int, 2016, 11:1-7.
12. Aurora SK, Brin MF. Chronic migraine:an update on physiology, imaging, and the mechanism of action of two available pharmacologic therapies[J/OL]. Headache, 2016:1-17. http://onlinelibrary.wiley.com/doi/10.1111/head.12999/abstract.
13. 吴江, 贾建平, 崔丽英, 等.神经病学[M]. 2版.北京:人民卫生出版社, 2010:314-315.
14. Karakurum B, Soylu O, Karataş M, et al. Personality, depression, and anxiety as risk factors for chronic migraine[J]. Int J Neurosci, 2004, 114(11):1391-1399.
15. Tan HJ, Suganthi C, Dhachayani S, et al. The coexistence of anxiety and depressive personality traits in migraine[J]. Singapore Med J, 2007, 48(4):307-310.
16. Da Silva AN, Lake IA. Clinical aspects of medication overuse headaches[J]. Headache, 2014, 54(1):211-217.
17. Cheung V, Amoozegar F, Dilli E. Medication overuse headache[J]. Curr Neurol Neurosci Rep, 2014, 15(1):509-517.
18. Munksgaard SB, Jensen RH. Medication overuse headache[J]. Headache, 2014, 54(7):1251-1257.

Previous Article
Clinical and Pathological Characteristics of Lung Carcinoma in Young Adults
Next Article
Study of Correlation between Inflammatory Factors and Multiple Factors of Acute Cerebral Infarction

West China Medical Journal

Analysis of Personalistic Characteristics in Patients with Migraine and Medication-overuse Headache

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content